Clinical trials
Phase 2 Pulmonary Arterial Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
116 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 8 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 13 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Terminated | 26 |
| Recruiting | 12 |
| Not yet recruiting | 7 |
| Withdrawn | 6 |
| Unknown status | 5 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 6 |
| Novartis Pharmaceuticals | 5 |
| United Therapeutics | 5 |
| Bastiaan Driehuys | 4 |
| GlaxoSmithKline | 4 |
| Lung Biotechnology PBC | 4 |
| Merck Sharp & Dohme LLC | 4 |
| University of Pennsylvania | 4 |
| Gilead Sciences | 3 |
| Imperial College London | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 116 |
| Hypertension, Pulmonary | 38 |
| Familial Primary Pulmonary Hypertension | 9 |
| Lung Diseases, Interstitial | 5 |
| Connective Tissue Diseases | 4 |
| Idiopathic Pulmonary Fibrosis | 4 |
| Lung Diseases | 4 |
| Cardiovascular Diseases | 3 |
| Hypertension | 3 |
| Vascular Diseases | 3 |
Trials
Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.
16 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.